L’Oréal is making a significant move toward sustainable beauty production by investing in Veminsyn, a promising biotechnology startup founded by four doctoral students from prestigious universities in Beijing. This strategic investment, which amounts to approximately 100 million renminbi (around $13.8 million), is currently pending regulatory approval. The funding round was spearheaded by L’Oréal’s China fund, alongside support from Shanghai Meicifang Investment Co., Ltd., its corporate venture capital arm, Bold, and Nice Group, a leading manufacturer in the personal care sector. This collaboration demonstrates L’Oréal’s commitment to innovating within the beauty industry by utilizing bio-active ingredients and focusing on localized supply chains.
The investment aims to revolutionize the development and production of bioactive ingredients that are sustainable and environmentally friendly. Through their partnership with Veminsyn, L’Oréal plans to promote the large-scale manufacturing of these innovative materials while employing low-carbon biomanufacturing techniques. Veminsyn articulated their mission on their official WeChat account, emphasizing the importance of not only creating compelling products but also doing so in a manner that respects our planet. This approach aligns with the growing demand among consumers for products that are not only effective but also ethically sourced and environmentally friendly.
Vincent Boinay, L’Oréal’s CEO for China and president of the North Asia Zone, expressed his enthusiasm for this venture, highlighting his belief in the game’s potential for innovation within the Chinese market. According to Boinay, Veminsyn stood out due to its exceptional capabilities in biotechnology, which he believes will significantly contribute to L’Oréal’s mission of developing sustainable ingredients. This investment reflects L’Oréal’s recognition of the dynamic and rapidly evolving Chinese startup ecosystem, which they aim to leverage for accelerated progress in developing new beauty solutions.
The collaboration between L’Oréal and Veminsyn is further reinforced by the insights of Barbara Lavernos, deputy CEO of research, innovation, and technology at L’Oréal. She explained that the partnership would bring together Veminsyn’s advanced AI design platforms with L’Oréal’s extensive scientific expertise in skin, hair, and scalp biology. The shared ambition is to streamline the pathway from the initial design of high-performing bioactives to their large-scale production, ensuring that beneficial products reach consumers quicker and more efficiently than ever before.
At the helm of Veminsyn is Yaran Zhao, who not only holds a doctorate in biology but is also the company’s largest shareholder. Zhao’s passion for biotechnology is evident in his vision for creating sustainable bioactive ingredients. He believes that the partnership with L’Oréal presents a unique opportunity to expedite the delivery of these innovative solutions globally. The excitement surrounding the collaboration stems from their shared goal of harnessing sustainable sources while meeting the rising demand for cutting-edge skincare solutions.
Founded in 2021, Veminsyn has already made substantial strides within the beauty tech landscape. The company leverages AI-driven tools to create bioactive skincare products that combat aging, catering to notable clients such as Proya, Jahwa, and Bloomage. Their journey took a notable turn in 2022 when they secured an impressive 100 million renminbi Series A funding round, backed by notable investors including Citic Capital and Zhen Fund. This trajectory, highlighted by both financial backing and innovation-led growth, positions Veminsyn as a key player in the biotechnology space within the beauty industry, illustrating the power of combining entrepreneurial spirit with scientific advancement.
